Clinical Trials Browser

Phase 2/3 × Neoplasms × Levofloxacin × Clear all

NCT00215007 2007-11-30

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Phase 2/3 Unknown

Neoplasms